Literature DB >> 11522500

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy.

T Yuuki1, T Kanda, Y Kimura, N Kotajima, J Tamura, I Kobayashi, S Kishi.   

Abstract

To determine whether inflammatory cytokines are increased in proliferative diabetic retinopathy. We measured concentrations of interleukin-6, 8 (IL-6, 8) and tumor necrosis factor (TNF)-alpha by enzyme-linked immunosorbent assay (ELISA) in vitreous and serum from 47 patients with proliferative diabetic retinopathy and 21 patients with vitreous noninflammatory retinopathies. Vitreous concentration of IL-6 were 64.7+/-12.8 pg/ml in proliferative diabetic retinopathy, much greater (P<.005) than in noninflammatory retinopathy (2.8+/-4.5 pg/ml). Amounts of IL-8 in vitreous fluid also were greater in proliferative retinopathy than in noninflammatory retinopathy (34.0+/-11.5 vs. 6.1+/-2.0 pg/ml, P<.005). Concentrations of TNF-alpha in vitreous fluid were not statistically different in proliferative retinopathy from those in noninflammatory retinopathy. In sera, concentrations of IL-6 and IL-8 were not different between proliferative and noninflammatory retinopathy. However, serum TNF-alpha was much greater in proliferative retinopathy than in noninflammatory retinopathy (0.81+/-0.72 vs. 0.09+/-0.00 pg/ml, P<.001). Elevated TNF-alpha in serum then may be diagnostically useful in proliferative diabetic retinopathy. And inflammatory cytokines in vitreous may be pathogenically important in this concentration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522500     DOI: 10.1016/s1056-8727(01)00155-6

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  75 in total

Review 1.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

2.  Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Authors:  Tammy L Palenski; Christine M Sorenson; Nader Sheibani
Journal:  Microvasc Res       Date:  2013-06-24       Impact factor: 3.514

3.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

Review 4.  Novel Therapies in Development for Diabetic Macular Edema.

Authors:  Aniruddha Agarwal; Rubbia Afridi; Muhammad Hassan; Mohammad Ali Sadiq; Yasir J Sepah; Diana V Do; Quan Dong Nguyen
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 5.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

6.  Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory.

Authors:  Pooi-See Chan; Mamta Kanwar; Renu A Kowluru
Journal:  J Diabetes Complications       Date:  2008-12-03       Impact factor: 2.852

7.  Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.

Authors:  Takeru Yoshimura; Koh-hei Sonoda; Mika Sugahara; Yasutaka Mochizuki; Hiroshi Enaida; Yuji Oshima; Akifumi Ueno; Yasuaki Hata; Hiroki Yoshida; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

8.  Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy.

Authors:  Snježana Kaštelan; Martina Tomić; Josip Pavan; Slavko Orešković
Journal:  Reprod Biol Endocrinol       Date:  2010-10-21       Impact factor: 5.211

9.  The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease.

Authors:  Gerasimos E Krassas; Themistoklis Tzotzas; Konstantinos Papazisis; Kaliopi Pazaitou-Panayiotou; Kostas Boboridis
Journal:  Clin Ophthalmol       Date:  2007-09

10.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.